Data gathered: April 21
AI Stock Analysis - Scpharmaceuticals (SCPH)
Analysis generated March 4, 2025. Powered by Chat GPT.
Scpharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative products for the treatment of serious medical conditions, with a focus on critical care therapies. The company's leading pipeline candidate aims to address unmet needs in the market, potentially improving patient outcomes and healthcare efficiencies. Scpharmaceuticals' commitment to innovation and quality is a cornerstone of its strategic objectives.
Stock Alerts - Scpharmaceuticals (SCPH)
 |
Scpharmaceuticals | April 14 Price is up by 7.3% in the last 24h. |
|
Scpharmaceuticals | April 11 Price is up by 7.7% in the last 24h. |
|
Scpharmaceuticals | April 10 Price is down by -7.3% in the last 24h. |
|
Scpharmaceuticals | April 9 Price is down by -5.6% in the last 24h. |
Alternative Data for Scpharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,651 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Scpharmaceuticals
scPharmaceuticals Inc., a pharmaceutical company, is engaged in the development and commercialization of various pharmaceutical products. The company is headquartered in Burlington, Massachusetts.
| Price | $2.59 |
| Target Price | Sign up |
| Volume | 49,220 |
| Market Cap | $129M |
| Year Range | $2.02 - $5.51 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Mitsubishi UFJ Asset Management Co. Ltd. Has $84,000 Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)April 5 - ETF Daily News |
|
Charles Schwab Investment Management Inc. Grows Position in scPharmaceuticals Inc. (NASDAQ:SCPH)April 2 - ETF Daily News |
|
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by Bank of New York Mellon CorpMarch 30 - ETF Daily News |
|
Thrivent Financial for Lutherans Decreases Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)March 26 - ETF Daily News |
 |
scPharmaceuticals’ (SCPH) “Buy” Rating Reiterated at HC WainwrightMarch 22 - ETF Daily News |
|
Maxim Group Has Lowered Expectations for scPharmaceuticals (NASDAQ:SCPH) Stock PriceMarch 22 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 3.3M | -6.3M | -35M | 0 | 0.000 |
| Q2 '24 | 8.1M | 2.3M | 5.8M | -17M | -14M | -0.440 |
| Q1 '24 | 4M | 1.8M | 2.2M | -14M | -16M | -0.360 |
| Q4 '23 | 4M | 1.8M | 2.2M | -14M | -15M | -0.350 |
| Q3 '23 | 1.7M | 1.1M | 660,000 | -16M | -15M | -0.410 |
Insider Transactions View All
| ORBIMED ADVISORS LLC filed to buy 252,858 shares at $4. August 15 '24 |
| ORBIMED ADVISORS LLC filed to buy 5,806,670 shares at $4. August 15 '24 |
| ORBIMED ADVISORS LLC filed to buy 5,328,328 shares at $5.3. November 29 '22 |
| ROCKLAGE SCOTT M filed to sell 92,983 shares at $4.1. October 11 '22 |
| ROCKLAGE SCOTT M filed to sell 410,268 shares at $4.1. October 11 '22 |
Similar companies
Read more about Scpharmaceuticals (SCPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, news mentions & customer reviews.
What is the Market Cap of Scpharmaceuticals?
The Market Cap of Scpharmaceuticals is $129M.
What is the current stock price of Scpharmaceuticals?
Currently, the price of one share of Scpharmaceuticals stock is $2.59.
How can I analyze the SCPH stock price chart for investment decisions?
The SCPH stock price chart above provides a comprehensive visual representation of Scpharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Scpharmaceuticals shares. Our platform offers an up-to-date SCPH stock price chart, along with technical data analysis and alternative data insights.
Does SCPH offer dividends to its shareholders?
As of our latest update, Scpharmaceuticals (SCPH) does not offer dividends to its shareholders. Investors interested in Scpharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Scpharmaceuticals?
Some of the similar stocks of Scpharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.